Genomics BioSci & Tech. Co.,Ltd. (4195.TWO)
TWD 16.15
(-9.01%)
TWD 16.15
(-9.01%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 30.57 Million TWD | 134.68% |
| 2022 | -88.16 Million TWD | -320.57% |
| 2021 | -20.96 Million TWD | 94.15% |
| 2020 | -358.39 Million TWD | -2.79% |
| 2019 | -348.68 Million TWD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 112.57 Million TWD | 6.13% |
| 2024 Q1 | 121.82 Million TWD | 298.4% |
| 2023 FY | 30.57 Million TWD | 134.68% |
| 2023 Q3 | 24.06 Million TWD | 126.45% |
| 2023 Q2 | -91 Million TWD | 5.09% |
| 2023 Q4 | 30.57 Million TWD | 27.05% |
| 2023 Q1 | -95.88 Million TWD | -8.75% |
| 2022 Q3 | -92.91 Million TWD | 0.0% |
| 2022 Q4 | -88.16 Million TWD | 5.11% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | -77.04 Million TWD | 139.689% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | -264.16 Million TWD | 111.575% |
| Level Biotechnology Inc. | -453.9 Million TWD | 106.737% |
| Sagittarius Life Science Corp | -120.57 Million TWD | 125.361% |
| NeoCore Technology Co., Ltd. | -196.39 Million TWD | 115.569% |
| TaiMed Biologics Inc. | 499.84 Million TWD | 93.883% |
| GlycoNex Incorporation | -148.56 Million TWD | 120.582% |
| VBI | -25.31 Million TWD | 220.785% |
| GeneReach Biotechnology Corp. | 40.26 Million TWD | 24.06% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 137.99 Million TWD | 77.841% |
| SynCore Biotechnology Co.,Ltd | -262.58 Million TWD | 111.645% |
| Visgeneer Inc. | 31.28 Million TWD | 2.257% |
| Mycenax Biotech Inc. | 207 Million TWD | 85.229% |
| Sunmax Biotechnology Co., Ltd. | -680.6 Million TWD | 104.493% |
| G&E Herbal Biotechnology Co., Ltd. | -134.25 Million TWD | 122.777% |
| Neith Corporation | -150.31 Million TWD | 120.343% |
| Medigen Vaccine Biologics Corporation | 621.53 Million TWD | 95.08% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -57.65 Million TWD | 153.033% |
| Enimmune corporation | -314.15 Million TWD | 109.733% |
| TaiRx, Inc. | -147.86 Million TWD | 120.679% |
| CHO Pharma, Inc. | -203.79 Million TWD | 115.005% |
| EirGenix Inc. | -4.58 Billion TWD | 100.666% |
| BioLASCO Taiwan Co., Ltd. | -84.76 Million TWD | 136.075% |
| Sunny Pharmtech Inc. | 120.87 Million TWD | 74.702% |
| Lin BioScience, Inc. | -3.21 Billion TWD | 100.95% |
| BioGend Therapeutics Co., Ltd. | -317.41 Million TWD | 109.633% |
| Feng Chi Biotech Corp. | -19.81 Million TWD | 254.333% |
| Bio Preventive Medicine Corp. | 31.8 Million TWD | 3.87% |
| Lukas Biomedical Inc. | 50.75 Million TWD | 39.754% |
| RBC Bioscience Corporation | 422.18 Million TWD | 92.757% |
| BiOptic Inc. | 12.59 Million TWD | -142.837% |
| BRIM Biotechnology, Inc. | -944.4 Million TWD | 103.238% |
| Shine-On BioMedical Co.,Ltd. | -101.48 Million TWD | 130.13% |
| Great Novel Therapeutics Biotech & Medicals | -165.17 Million TWD | 118.512% |
| Syngen Biotech Co.,Ltd. | 314.87 Million TWD | 90.289% |
| Advagene Biopharma Co., Ltd. | -64.32 Million TWD | 147.54% |
| NaviFUS Corp. | -123.12 Million TWD | 124.834% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 74.05 Million TWD | 58.707% |
| Sinew Pharma Inc. | -160.34 Million TWD | 119.07% |
| Andros Pharmaceuticals Co.,Ltd | -241.89 Million TWD | 112.641% |
| Greenyn Biotechnology Co., Ltd | -337.37 Million TWD | 109.064% |
| Lumosa Therapeutics Co., Ltd. | -412.63 Million TWD | 107.41% |
| AP Biosciences Inc | -196.52 Million TWD | 115.559% |
| Medigen Biotechnology Corp. | 688.73 Million TWD | 95.56% |
| 3D Global Biotech Inc. | -11.43 Million TWD | 367.36% |
| Pharmosa Biopharm Inc. | -829.69 Million TWD | 103.685% |
| Intech Biopharm Corporation | 1.35 Billion TWD | 97.747% |
| Oneness Biotech Co., Ltd. | -414.87 Million TWD | 107.37% |
| Eusol Biotech Co.,Ltd. | -209.33 Million TWD | 114.607% |
| TWi Biotechnology, Inc. | -143.86 Million TWD | 121.255% |
| Ever Supreme Bio Technology Co., Ltd | -330.54 Million TWD | 109.251% |
| TCI GENE Inc. | -689.25 Million TWD | 104.436% |
| MegaPro Biomedical Co., Ltd | -118.93 Million TWD | 125.709% |
| Senhwa Biosciences, Inc. | -1.3 Billion TWD | 102.336% |
| Taiwan Bio Therapeutics Co., Ltd | 20.48 Million TWD | -49.285% |
| NatureWise Biotech & Medicals Corporation | -101.87 Million TWD | 130.017% |
| PharmaEngine, Inc. | -860.8 Million TWD | 103.552% |
| Savior Lifetec Corporation | -812.54 Million TWD | 103.763% |
| TaiGen Biopharmaceuticals Holdings Limited | -299.96 Million TWD | 110.194% |
| OBI Pharma, Inc. | -398.22 Million TWD | 107.679% |
| Meribank Biotech Co., Ltd | -365.41 Million TWD | 108.368% |
| Acepodia, Inc. | -6.02 Billion TWD | 100.508% |
| Caliway Biopharmaceuticals Co., Ltd. | -3.4 Billion TWD | 100.899% |